Corvus Pharmaceuticals In...

NASDAQ: CRVS · Real-Time Price · USD
5.42
0.57 (11.75%)
At close: Aug 15, 2025, 3:59 PM
5.43
0.28%
After-hours: Aug 15, 2025, 07:49 PM EDT

Corvus Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-5.24 -3.13 -0.96 -2.33
PEG Ratio
-0.06 0.08 0.07 -0.01
PS Ratio
n/a n/a n/a n/a
PB Ratio
10.02 2.18 0.71 1.04
P/FCF Ratio
-12.83 -3.53 -1.45 -2.75
P/OCF Ratio
-12.83 -3.53 -1.46 -2.75
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.03 0.04 0.05 0.04
Quick Ratio
1.54 4.07 4.13 7.43
Current Ratio
1.54 4.07 4.06 7.36
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-15.1 -14.78 -49.79 -2.58K
Return on Equity
-1.91 -0.7 -0.74 -0.45
Return on Assets
-0.9 -0.59 -0.61 -0.4
Return on Invested Capital
-0.81 -0.56 -0.53 -0.37
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a